Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Astrid Thuerigen"'
Autor:
Komal Jhaveri, Joyce O’Shaughnessy, Peter A. Fasching, Sara M. Tolaney, Denise A. Yardley, Vikash Kumar Sharma, Chandroday Biswas, Astrid Thuerigen, Purnima Pathak, Hope S. Rugo
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background: Current standard-of-care first-line treatment of patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2−) advanced breast cancer (ABC) is cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) + end
Externí odkaz:
https://doaj.org/article/f9fa04a73b63440b97588ebecf3c53a7
